Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Moleculin Biotech, Inc. has filed 821 SEC EDGAR filings since 04 Dec 2015

SEC filing history

Showing 51-75 of 821 matching filings.

Per page
25
Current page
3
EFFECT File 333-292420

EFFECT filing

Filing date
06 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37758

FORM DEF 14A

Filing date
02 Jan 2026
Reporting date
05 Feb 2026
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-292420

UPLOAD filing

Filing date
02 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-280064

FORM 424B5

Filing date
23 Dec 2025
Reporting date
Not listed
Next action
Verify source filing
PRER14A File 001-37758

FORM PRER14A

Filing date
22 Dec 2025
Reporting date
Not listed
Next action
Verify source filing
PRE 14A File 001-37758

FORM PRE 14A

Filing date
19 Dec 2025
Reporting date
05 Feb 2026
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .